kezar life sciences market cap

Find the latest Market Cap for Kezar Life Sciences KZR. View Kezar Life Sciences Incs Market Cap trends charts and more.

Deck Review With Kezar Life Sciences By Joshua Elkington

Kezar Life Sciences Inc.

. SOUTH SAN FRANCISCO Calif November 03 2022--Kezar Life Sciences Inc. On November 3 2022 the Company issued a press release reporting its presentation of the complete results from its MISSION Phase 2 clinical trial. KZR has a market cap or net worth of 51482 million as of October 31 2022 making it the 3115th biggest public company in the US.

Historical Market Cap Data. Kezar Life Sciences Inc. Item 801 Other Events.

Kezar Life Sciencess latest twelve months book value market cap is 02x. Earnings for Kezar Life Sciences KZR Earnings in 2022 TTM. At the end of 2021 the company had a PE ratio of.

Market cap market capitalization is the total market value of a publicly traded companys outstanding shares. According to Kezar Life Sciencess latest financial reports and stock price the companys current price-to-earnings ratio TTM is -963461. View and export this data back to 2018.

The firm has a market capitalization of 45372 million a PE ratio of -722 and a beta of 026. 10 Day Average Volume 0. As of October 2022 Kezar Life Sciencess TTM revenue is of NA.

KZRs market cap has increased by. Kezar Life Sciencess market cap is 2775 million. Shares of NASDAQ KZR opened at 751 on Wednesday.

Kezar Announces Inducement Grant Under. Before that he was an equity research associate at BMO Capital Markets covering SMID-cap biotechnology companies. View Kezar Life Sciences Incs Book Value Market Cap trends charts and more.

Kezar Life Sciences s market cap is calculated by multiplying. Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in. KZR a clinical-stage biotechnology company discovering and developing.

Kezar Life Sciences Inc. Market Cap 51380M. Current and historical revenue charts for Kezar Life Sciences.

Prior to the launch of Kezar Life Sciences in 2015 Mr. 7065 total market cap. Market Cap is a widely used stock evaluation measure.

8822 Million USD as of April 1 2022 business Kezar Life Sciences Inc. Company Profile Kezar Life Sciences Inc. Kezar Life Sciences Market Cap.

Historical data for the end-year market capitalization of Kezar Life Sciences Inc. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic. Kezar Life Sciences Inc has a market cap of 0503 billion indicating a price to book ratio of 1759 and a price to sales ratio of -.

Kezar Life Sciences Incs Key Ratios. In the last 12-months. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune.

Kezar Life Sciences stock price forecast. Market capitalization or market value is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the. 03112022 - Kezar Life Sciences Inc.

-6089 M According to Kezar Life Sciencess latest financial reports the companys current earnings TTM are -6089 MIn. Is a clinical-stage biopharmaceutical company that is focused on discovering.

Kzr Institutional Ownership And Shareholders Kezar Life Sciences Inc Nasdaq Stock